img

Global Lonotropic Glutamate Receptor Antagonist Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lonotropic Glutamate Receptor Antagonist Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Ionic glutamate receptor antagonists, includingthe N-methyl-D-aspartate receptor, the maricin receptor, and the alpha-amino-3-hydroxy-5 methyl-4 isoxazole receptor, which are coupled to ion channels to form receptor channel complexes that mediate fast signalling.
Lonotropic Glutamate Receptor Antagonist report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lonotropic Glutamate Receptor Antagonist market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lonotropic Glutamate Receptor Antagonist industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lonotropic Glutamate Receptor Antagonist key manufacturers include Artemis Neuroscience, VistaGen Therapeutics, Rottapharm Madaus, Amorsa Therapeutics, Newron Pharmaceuticals, Purdue Biopharma, Relmada Therapeutics, BioCrea GmbH and Cerecor Inc., etc. Artemis Neuroscience, VistaGen Therapeutics, Rottapharm Madaus are top 3 players and held % sales share in total in 2022.
Lonotropic Glutamate Receptor Antagonist can be divided into N-Methyl-D-Aspartate Receptors, Marine Human Alginate Receptors and α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors,, etc. N-Methyl-D-Aspartate Receptors is the mainstream product in the market, accounting for % sales share globally in 2022.
Lonotropic Glutamate Receptor Antagonist is widely used in various fields, such as Hospitals, Clinics, Research Institutes and Others, etc. Hospitals provides greatest supports to the Lonotropic Glutamate Receptor Antagonist industry development. In 2022, global % sales of Lonotropic Glutamate Receptor Antagonist went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lonotropic Glutamate Receptor Antagonist market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc.
NeurOp Inc.
UCB SA
Novartis AG
Luc Therapeutics Inc.
Evotec AG
Segment by Type
N-Methyl-D-Aspartate Receptors
Marine Human Alginate Receptors
α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors

Segment by Application


Hospitals
Clinics
Research Institutes
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lonotropic Glutamate Receptor Antagonist market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lonotropic Glutamate Receptor Antagonist, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lonotropic Glutamate Receptor Antagonist industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Lonotropic Glutamate Receptor Antagonist in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lonotropic Glutamate Receptor Antagonist introduction, etc. Lonotropic Glutamate Receptor Antagonist Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Lonotropic Glutamate Receptor Antagonist market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Lonotropic Glutamate Receptor Antagonist Market Overview
1.1 Lonotropic Glutamate Receptor Antagonist Product Overview
1.2 Lonotropic Glutamate Receptor Antagonist Market Segment by Type
1.2.1 N-Methyl-D-Aspartate Receptors
1.2.2 Marine Human Alginate Receptors
1.2.3 α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
1.3 Global Lonotropic Glutamate Receptor Antagonist Market Size by Type
1.3.1 Global Lonotropic Glutamate Receptor Antagonist Market Size Overview by Type (2024-2034)
1.3.2 Global Lonotropic Glutamate Receptor Antagonist Historic Market Size Review by Type (2024-2024)
1.3.3 Global Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Type (2024-2024)
1.4.2 Europe Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Type (2024-2024)
2 Global Lonotropic Glutamate Receptor Antagonist Market Competition by Company
2.1 Global Top Players by Lonotropic Glutamate Receptor Antagonist Sales (2024-2024)
2.2 Global Top Players by Lonotropic Glutamate Receptor Antagonist Revenue (2024-2024)
2.3 Global Top Players by Lonotropic Glutamate Receptor Antagonist Price (2024-2024)
2.4 Global Top Manufacturers Lonotropic Glutamate Receptor Antagonist Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lonotropic Glutamate Receptor Antagonist Market Competitive Situation and Trends
2.5.1 Lonotropic Glutamate Receptor Antagonist Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Lonotropic Glutamate Receptor Antagonist Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lonotropic Glutamate Receptor Antagonist as of 2022)
2.7 Date of Key Manufacturers Enter into Lonotropic Glutamate Receptor Antagonist Market
2.8 Key Manufacturers Lonotropic Glutamate Receptor Antagonist Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lonotropic Glutamate Receptor Antagonist Status and Outlook by Region
3.1 Global Lonotropic Glutamate Receptor Antagonist Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Lonotropic Glutamate Receptor Antagonist Historic Market Size by Region
3.2.1 Global Lonotropic Glutamate Receptor Antagonist Sales in Volume by Region (2024-2024)
3.2.2 Global Lonotropic Glutamate Receptor Antagonist Sales in Value by Region (2024-2024)
3.2.3 Global Lonotropic Glutamate Receptor Antagonist Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Region
3.3.1 Global Lonotropic Glutamate Receptor Antagonist Sales in Volume by Region (2024-2034)
3.3.2 Global Lonotropic Glutamate Receptor Antagonist Sales in Value by Region (2024-2034)
3.3.3 Global Lonotropic Glutamate Receptor Antagonist Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Lonotropic Glutamate Receptor Antagonist by Application
4.1 Lonotropic Glutamate Receptor Antagonist Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Research Institutes
4.1.4 Others
4.2 Global Lonotropic Glutamate Receptor Antagonist Market Size by Application
4.2.1 Global Lonotropic Glutamate Receptor Antagonist Market Size Overview by Application (2024-2034)
4.2.2 Global Lonotropic Glutamate Receptor Antagonist Historic Market Size Review by Application (2024-2024)
4.2.3 Global Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Application (2024-2024)
4.3.2 Europe Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Breakdown by Application (2024-2024)
5 North America Lonotropic Glutamate Receptor Antagonist by Country
5.1 North America Lonotropic Glutamate Receptor Antagonist Historic Market Size by Country
5.1.1 North America Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2024)
5.1.3 North America Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2024)
5.2 North America Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Country
5.2.1 North America Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2034)
5.2.2 North America Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2034)
6 Europe Lonotropic Glutamate Receptor Antagonist by Country
6.1 Europe Lonotropic Glutamate Receptor Antagonist Historic Market Size by Country
6.1.1 Europe Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2024)
6.1.3 Europe Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2024)
6.2 Europe Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Country
6.2.1 Europe Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2034)
6.2.2 Europe Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2034)
7 Asia-Pacific Lonotropic Glutamate Receptor Antagonist by Region
7.1 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Historic Market Size by Region
7.1.1 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Region
7.2.1 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales in Value by Region (2024-2034)
8 Latin America Lonotropic Glutamate Receptor Antagonist by Country
8.1 Latin America Lonotropic Glutamate Receptor Antagonist Historic Market Size by Country
8.1.1 Latin America Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2024)
8.1.3 Latin America Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2024)
8.2 Latin America Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Country
8.2.1 Latin America Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2034)
8.2.2 Latin America Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2034)
9 Middle East and Africa Lonotropic Glutamate Receptor Antagonist by Country
9.1 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Historic Market Size by Country
9.1.1 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Forecasted Market Size by Country
9.2.1 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Artemis Neuroscience
10.1.1 Artemis Neuroscience Company Information
10.1.2 Artemis Neuroscience Introduction and Business Overview
10.1.3 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Products Offered
10.1.5 Artemis Neuroscience Recent Development
10.2 VistaGen Therapeutics
10.2.1 VistaGen Therapeutics Company Information
10.2.2 VistaGen Therapeutics Introduction and Business Overview
10.2.3 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.2.4 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Products Offered
10.2.5 VistaGen Therapeutics Recent Development
10.3 Rottapharm Madaus
10.3.1 Rottapharm Madaus Company Information
10.3.2 Rottapharm Madaus Introduction and Business Overview
10.3.3 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Products Offered
10.3.5 Rottapharm Madaus Recent Development
10.4 Amorsa Therapeutics
10.4.1 Amorsa Therapeutics Company Information
10.4.2 Amorsa Therapeutics Introduction and Business Overview
10.4.3 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Products Offered
10.4.5 Amorsa Therapeutics Recent Development
10.5 Newron Pharmaceuticals
10.5.1 Newron Pharmaceuticals Company Information
10.5.2 Newron Pharmaceuticals Introduction and Business Overview
10.5.3 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Products Offered
10.5.5 Newron Pharmaceuticals Recent Development
10.6 Purdue Biopharma
10.6.1 Purdue Biopharma Company Information
10.6.2 Purdue Biopharma Introduction and Business Overview
10.6.3 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Products Offered
10.6.5 Purdue Biopharma Recent Development
10.7 Relmada Therapeutics
10.7.1 Relmada Therapeutics Company Information
10.7.2 Relmada Therapeutics Introduction and Business Overview
10.7.3 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Products Offered
10.7.5 Relmada Therapeutics Recent Development
10.8 BioCrea GmbH
10.8.1 BioCrea GmbH Company Information
10.8.2 BioCrea GmbH Introduction and Business Overview
10.8.3 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.8.4 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Products Offered
10.8.5 BioCrea GmbH Recent Development
10.9 Cerecor Inc.
10.9.1 Cerecor Inc. Company Information
10.9.2 Cerecor Inc. Introduction and Business Overview
10.9.3 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Products Offered
10.9.5 Cerecor Inc. Recent Development
10.10 NeurOp Inc.
10.10.1 NeurOp Inc. Company Information
10.10.2 NeurOp Inc. Introduction and Business Overview
10.10.3 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.10.4 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Products Offered
10.10.5 NeurOp Inc. Recent Development
10.11 UCB SA
10.11.1 UCB SA Company Information
10.11.2 UCB SA Introduction and Business Overview
10.11.3 UCB SA Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.11.4 UCB SA Lonotropic Glutamate Receptor Antagonist Products Offered
10.11.5 UCB SA Recent Development
10.12 Novartis AG
10.12.1 Novartis AG Company Information
10.12.2 Novartis AG Introduction and Business Overview
10.12.3 Novartis AG Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Novartis AG Lonotropic Glutamate Receptor Antagonist Products Offered
10.12.5 Novartis AG Recent Development
10.13 Luc Therapeutics Inc.
10.13.1 Luc Therapeutics Inc. Company Information
10.13.2 Luc Therapeutics Inc. Introduction and Business Overview
10.13.3 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Products Offered
10.13.5 Luc Therapeutics Inc. Recent Development
10.14 Evotec AG
10.14.1 Evotec AG Company Information
10.14.2 Evotec AG Introduction and Business Overview
10.14.3 Evotec AG Lonotropic Glutamate Receptor Antagonist Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Evotec AG Lonotropic Glutamate Receptor Antagonist Products Offered
10.14.5 Evotec AG Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lonotropic Glutamate Receptor Antagonist Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lonotropic Glutamate Receptor Antagonist Industrial Chain Analysis
11.4 Lonotropic Glutamate Receptor Antagonist Market Dynamics
11.4.1 Lonotropic Glutamate Receptor Antagonist Industry Trends
11.4.2 Lonotropic Glutamate Receptor Antagonist Market Drivers
11.4.3 Lonotropic Glutamate Receptor Antagonist Market Challenges
11.4.4 Lonotropic Glutamate Receptor Antagonist Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lonotropic Glutamate Receptor Antagonist Distributors
12.3 Lonotropic Glutamate Receptor Antagonist Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of N-Methyl-D-Aspartate Receptors
Table 2. Major Company of Marine Human Alginate Receptors
Table 3. Major Company of α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
Table 4. Global Lonotropic Glutamate Receptor Antagonist Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (Units)
Table 6. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (US& Million)
Table 8. Global Lonotropic Glutamate Receptor Antagonist Market Share in Value by Type (2024-2024)
Table 9. Global Lonotropic Glutamate Receptor Antagonist Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2034) & (Units)
Table 11. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Type (2024-2034)
Table 14. Global Lonotropic Glutamate Receptor Antagonist Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (Units)
Table 16. North America Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Lonotropic Glutamate Receptor Antagonist Sales (Units) by Type (2024-2024)
Table 18. Europe Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales (Units) by Type (2024-2024)
Table 20. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Lonotropic Glutamate Receptor Antagonist Sales (Units) by Type (2024-2024)
Table 22. Latin America Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales (Units) by Type (2024-2024)
Table 24. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Lonotropic Glutamate Receptor Antagonist Sales by Company (2024-2024) & (Units)
Table 26. Global Lonotropic Glutamate Receptor Antagonist Sales Share by Company (2024-2024)
Table 27. Global Lonotropic Glutamate Receptor Antagonist Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Company (2024-2024)
Table 29. Global Market Lonotropic Glutamate Receptor Antagonist Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Lonotropic Glutamate Receptor Antagonist Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lonotropic Glutamate Receptor Antagonist as of 2022)
Table 33. Date of Key Manufacturers Enter into Lonotropic Glutamate Receptor Antagonist Market
Table 34. Key Manufacturers Lonotropic Glutamate Receptor Antagonist Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Lonotropic Glutamate Receptor Antagonist Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2024) & (Units)
Table 38. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Region (2024-2024)
Table 41. Global Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2034) & (Units)
Table 43. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Region (2024-2034)
Table 46. Global Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Lonotropic Glutamate Receptor Antagonist Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) & (Units)
Table 49. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Application (2024-2024)
Table 52. Global Lonotropic Glutamate Receptor Antagonist Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2034) & (Units)
Table 54. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Application (2024-2034)
Table 57. Global Lonotropic Glutamate Receptor Antagonist Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) (Units)
Table 59. North America Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) (Units)
Table 61. Europe Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) (Units)
Table 63. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) (Units)
Table 65. Latin America Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) (Units)
Table 67. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (Units)
Table 69. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2024)
Table 72. North America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (Units)
Table 73. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (Units)
Table 77. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (Units)
Table 81. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2024) & (Units)
Table 85. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2034) & (Units)
Table 89. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (Units)
Table 93. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (Units)
Table 97. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (Units)
Table 101. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (Units)
Table 105. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Country (2024-2034)
Table 108. Artemis Neuroscience Company Information
Table 109. Artemis Neuroscience Introduction and Business Overview
Table 110. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Product
Table 112. Artemis Neuroscience Recent Development
Table 113. VistaGen Therapeutics Company Information
Table 114. VistaGen Therapeutics Introduction and Business Overview
Table 115. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Product
Table 117. VistaGen Therapeutics Recent Development
Table 118. Rottapharm Madaus Company Information
Table 119. Rottapharm Madaus Introduction and Business Overview
Table 120. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Product
Table 122. Rottapharm Madaus Recent Development
Table 123. Amorsa Therapeutics Company Information
Table 124. Amorsa Therapeutics Introduction and Business Overview
Table 125. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Product
Table 127. Amorsa Therapeutics Recent Development
Table 128. Newron Pharmaceuticals Company Information
Table 129. Newron Pharmaceuticals Introduction and Business Overview
Table 130. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Product
Table 132. Newron Pharmaceuticals Recent Development
Table 133. Purdue Biopharma Company Information
Table 134. Purdue Biopharma Introduction and Business Overview
Table 135. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Product
Table 137. Purdue Biopharma Recent Development
Table 138. Relmada Therapeutics Company Information
Table 139. Relmada Therapeutics Introduction and Business Overview
Table 140. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Product
Table 142. Relmada Therapeutics Recent Development
Table 143. BioCrea GmbH Company Information
Table 144. BioCrea GmbH Introduction and Business Overview
Table 145. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Product
Table 147. BioCrea GmbH Recent Development
Table 148. Cerecor Inc. Company Information
Table 149. Cerecor Inc. Introduction and Business Overview
Table 150. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Product
Table 152. Cerecor Inc. Recent Development
Table 153. NeurOp Inc. Company Information
Table 154. NeurOp Inc. Introduction and Business Overview
Table 155. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Product
Table 157. NeurOp Inc. Recent Development
Table 158. UCB SA Company Information
Table 159. UCB SA Introduction and Business Overview
Table 160. UCB SA Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. UCB SA Lonotropic Glutamate Receptor Antagonist Product
Table 162. UCB SA Recent Development
Table 163. Novartis AG Company Information
Table 164. Novartis AG Introduction and Business Overview
Table 165. Novartis AG Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 166. Novartis AG Lonotropic Glutamate Receptor Antagonist Product
Table 167. Novartis AG Recent Development
Table 168. Luc Therapeutics Inc. Company Information
Table 169. Luc Therapeutics Inc. Introduction and Business Overview
Table 170. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 171. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Product
Table 172. Luc Therapeutics Inc. Recent Development
Table 173. Evotec AG Company Information
Table 174. Evotec AG Introduction and Business Overview
Table 175. Evotec AG Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 176. Evotec AG Lonotropic Glutamate Receptor Antagonist Product
Table 177. Evotec AG Recent Development
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Lonotropic Glutamate Receptor Antagonist Market Trends
Table 181. Lonotropic Glutamate Receptor Antagonist Market Drivers
Table 182. Lonotropic Glutamate Receptor Antagonist Market Challenges
Table 183. Lonotropic Glutamate Receptor Antagonist Market Restraints
Table 184. Lonotropic Glutamate Receptor Antagonist Distributors List
Table 185. Lonotropic Glutamate Receptor Antagonist Downstream Customers
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Lonotropic Glutamate Receptor Antagonist Product Picture
Figure 2. Global Lonotropic Glutamate Receptor Antagonist Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Lonotropic Glutamate Receptor Antagonist Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Lonotropic Glutamate Receptor Antagonist Sales Status and Outlook (2024-2034) & (Units)
Figure 5. Product Picture of N-Methyl-D-Aspartate Receptors
Figure 6. Global N-Methyl-D-Aspartate Receptors Sales YoY Growth (2024-2034) & (Units)
Figure 7. Product Picture of Marine Human Alginate Receptors
Figure 8. Global Marine Human Alginate Receptors Sales YoY Growth (2024-2034) & (Units)
Figure 9. Product Picture of α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
Figure 10. Global α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors Sales YoY Growth (2024-2034) & (Units)
Figure 11. Global Lonotropic Glutamate Receptor Antagonist Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type in 2022 & 2034
Figure 13. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Type in 2022
Figure 14. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Type in 2022
Figure 15. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Type in 2022
Figure 16. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Type in 2022
Figure 19. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Lonotropic Glutamate Receptor Antagonist Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Lonotropic Glutamate Receptor Antagonist Revenue in 2022
Figure 25. Lonotropic Glutamate Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospitals
Figure 27. Global Hospitals Sales YoY Growth (2024-2034) & (Units)
Figure 28. Product Picture of Clinics
Figure 29. Global Clinics Sales YoY Growth (2024-2034) & (Units)
Figure 30. Product Picture of Research Institutes
Figure 31. Global Research Institutes Sales YoY Growth (2024-2034) & (Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2024-2034) & (Units)
Figure 34. Global Lonotropic Glutamate Receptor Antagonist Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application in 2022 & 2034
Figure 36. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Application in 2022
Figure 37. North America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Application in 2022
Figure 38. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Application in 2022
Figure 39. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Application in 2022
Figure 42. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Lonotropic Glutamate Receptor Antagonist Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Lonotropic Glutamate Receptor Antagonist Manufacturing Cost Structure
Figure 47. Lonotropic Glutamate Receptor Antagonist Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries